Gilead’s Remdesivir Pricing Sets ‘Promising’ Precedent For Future COVID-19 Drugs

 
• By Cathy Kelly

Highly anticipated decision bodes well for pricing of other future treatments for the disease, the US Institute for Clinical and Economic Review suggests.

Corona patient
Pricing To Enable Access While Generating Profit

More from Pricing Debate

More from Market Access